Top Stock Upgrades Today in the Buzz

 StocksRunner
 
  StocksRunner
 
Follow  Message
 
 
 
Find out what happening right now and get all the pieces of the puzzle on important data activity before the major news sources break the story and see what are the trends
 

•  14 May 2026
 

$CSCO received the most consequential upgrade cluster of the session, with six major firms raising price targets to a range of $112 to $132 from a prior consensus of $89.54 after the company reported record fiscal Q3 2026 revenue of $15.84 billion, up 12% year over year, with total product orders accelerating 35% and AI infrastructure guidance lifted to $9 billion from $5 billion. The coordinated revision wave from KeyBanc, Piper Sandler, JPMorgan, Goldman Sachs, Bank of America, and Citi reflects a genuine thesis shift rather than a routine target bump, with Bank of America flagging that Q4 revenue growth guidance came in nearly double street expectations. The stock trades at a forward P/E of 21x, which remains reasonable for a name growing orders at this pace, and the in-house silicon design advantage cited by both BofA and Citi gives Cisco a supply constraint edge that most competitors lack right now.

$SBUX was raised to Buy from Hold at TD Cowen with a target lifted to $120 from $106, following a second-quarter beat where revenue of $9.53 billion and adjusted EPS of 50 cents both topped consensus by a meaningful margin. Management pointed to the strongest store traffic in three years, which is the metric that matters most for validating the turnaround thesis. The stock closed Wednesday at $105.95, leaving a clear gap to the new target, and the upgrade carries added weight because it arrives after the earnings reaction rather than ahead of it, meaning the analyst is endorsing the move with fresh data in hand rather than anticipating a catalyst.

$ILMN was raised to Outperform from Neutral at Daiwa with a $155 price target, a call that stands out given the genomics sector has been under sustained pressure from slower-than-expected clinical adoption cycles and budget tightening in life sciences. At a current price of $143.24, the target implies limited upside on its face, but the rating change from a firm that had been neutral signals growing conviction that the worst of the fundamental headwinds are priced in. Volume on the day came in above average at 2.01 million against a 1.56 million average, suggesting the upgrade drew real institutional attention rather than passive drift.

$HUT was initiated at Buy by Jefferies with a $156 price target against a current price of $109.37, representing meaningful implied upside in the Bitcoin mining space at a moment when the crypto complex is showing recovery signals after a volatile stretch. The Jefferies initiation paired with a simultaneous Buy initiation on $WULF with a $28 target suggests the firm is making a deliberate sector call on next-generation crypto infrastructure rather than a single-name view. TeraWulf traded at $24.17 on volume of 22.46 million against a 32.82 million average, slightly below trend, which may indicate the initiation has not yet been fully absorbed by the broader market.

$LOW was upgraded to Overweight from Equal Weight at Wells Fargo with a revised target of $260, down from $290, which is an unusual structure where the analyst upgrades the rating while simultaneously trimming the price objective. The mechanism here reflects a valuation call more than an earnings acceleration call: Wells Fargo appears to be arguing that the stock has sold off enough to warrant adding exposure even as the fundamental outlook remains subdued, with housing market sensitivity still a real drag given mortgage rates at their highest level since March. This is a buy-the-weakness upgrade rather than a buy-the-momentum upgrade, and the distinction matters for positioning.

$DOCS received a downgrade rather than an upgrade, cut to Hold from Buy at Jefferies with the price target slashed to $19 from $51 after the company missed Q4 earnings and guided fiscal 2027 revenue well below street expectations. The stock dropped 23% and closed at $18.01 on volume nearly 7.6 times its average, a punishing combination that signals the sell-side had been materially wrong on the growth trajectory. The guidance cut is the more damaging element because it removes the recoverable-miss narrative and forces a fundamental reassessment of the platform's long-term engagement assumptions.

View all market intelligence →